All News WalkMe Ltd.

Equities

WKME

IL0011765851

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
8.03 ^USD	+1.52%		+4.15%	-24.74%

Apr. 17	Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating	MT
Apr. 15	Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating	Apr. 17	MT
Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating	Apr. 15	MT
WalkMe Cements Category Leadership with Continued AI Innovation, Industry Recognition, and Financial Growth	Apr. 15	AQ
KeyBanc Initiates WalkMe at Sector Weight, Sees Revenue Reacceleration Taking Time, Margin Improvement 'Harder to Come by'	Mar. 21	MT
WalkMe Ltd. Files Annual Report on Form 20-F	Mar. 18	AQ
WalkMe to Present at Upcoming Investor Conference	Mar. 04	AQ
Wells Fargo Adjusts Price Target on WalkMe to $14 From $12, Maintains Overweight Rating	Feb. 22	MT
Transcript : WalkMe Ltd., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
WalkMe: Q4 Earnings Snapshot	Feb. 21	AQ
WalkMe Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	AQ
Walkme Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 21	CI
WalkMe Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
WalkMe Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
WalkMe Introduces Workflow Accelerators to Eliminate Friction in Workflows	Feb. 20	AQ
Walkme Ltd. Unveils Workflow Accelerators	Feb. 20	CI
Enterprises losing more than $1M a week through inefficient technology use, WalkMe report reveals	Feb. 07	AQ
WalkMe Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call	Feb. 06	AQ
Jim Nairn of WalkMe Recognized as 2024 CRN® Channel Chief	Feb. 05	AQ
Barclays Downgrades WalkMe to Underweight From Equalweight, Sets Price Target at $10	Jan. 12	MT
Morgan Stanley Lifts Price Target on WalkMe to $11 From $10, Keeps Equalweight Rating	Dec. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News WalkMe Ltd.

Equities

WKME

IL0011765851

All News

Filters